PARKER-HANNIFIN CORPORATION (PH): what the price requires
At today's price, PARKER-HANNIFIN CORPORATION (PH) is priced for today's economics sustained for ~8.8 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-13 · Source: https://boothcheck.com/report/PH
Headline
| Field | Value |
|---|---|
| Ticker | PH |
| Company | PARKER-HANNIFIN CORPORATION |
| Current price | $950.92/sh |
| Composition | Diversified Industrial 69% / Aerospace Systems 31% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 21.7% |
| Operating margin today | 22.7% |
| Margin compression implied | -1.0pp |
| Must persist for | 8.8y |
| Multiple paid | 29x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 10.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~1.9 years.
Reconcile: at the x-ray's 9.3% required return this reads ~5.8 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +1.44σ |
| cohort percentile (of 225 peers) | 67 |
| sustained it ~8.8 years at this level | 17% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.23x | 5 | expensive |
| Earnings | 3.24x | 5 | expensive |
| Relative | 2.32x | 5 | expensive |
| Growth | 1.27x | 3 | expensive |
Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=18)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $594.11 | 1.60x | yes | FCF base $3.8B, growth 6% (input: historical growth), terminal g 4.0%, WACC 9.2%, 6yr projection |
| DCF Exit Multiple | Growth | $871.43 | 1.09x | yes | Exit EV/EBITDA: 22.0x / 24.0x / 26.0x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $639.80 | 1.49x | yes | P/E 23.09x (blended: sector 18x + trailing (TTM) 35x), scenarios: 19.3x / 23.1x / 26.9x (bear / base = sector held flat / bull), EV/EBITDA 15.6x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $293.97 | 3.23x | yes | BV/sh $114.13, ROE (TTM) 23.8%, ke 9.3% |
| Two-Stage Excess Return | Asset | $472.05 | 2.01x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $750.68 | 1.27x | yes | Rev $21.0B, growth 6% (input: historical growth; tapered), Terminal P/S: 4.8x / 5.8x / 6.8x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $325.32 | 2.92x | yes | EPS $27.11, growth 6% (input: historical EPS growth), PEG=6.14 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $250.94 | 3.79x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $3.82B × (1−19%) / WACC 9.2% → EPV (no growth) |
| Residual Income | Asset | $430.43 | 2.21x | yes | BV $114.13 + 5yr PV of (ROE (TTM) 23.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $263.85 | 3.60x | yes | √(22.5 × EPS $27.11 × BVPS $114.13) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $468.96 | 2.03x | yes | EBITDA $5.14B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $297.99 | 3.19x | yes | FCF $3678.4M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $283.27 | 3.36x | yes | SBC-adj FCF $3.50B (FCF $3.68B − SBC $0.17B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $451.81 | 2.10x | yes | EPS $27.11 × (8.5 + 2×5.7%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $76.23 | 12.47x | yes | BV $114.13 × (ROIC 6.1% / WACC 9.2%) |
| P/Sales Sector | Relative | $409.90 | 2.32x | yes | Revenue $20.99B × sector P/S 2.5x |
| PEG Fair Value | Relative | $231.49 | 4.11x | yes | EPS $27.11 × (PEG 1.5 × growth 5.7% (input: historical EPS growth)) → PE 8.5x |
| Earnings Yield | Earnings | $293.08 | 3.24x | yes | EPS $27.11 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $9.2b |
| Net debt / NOPAT (after-tax) | 2.43x |
| Net debt / operating income (pre-tax) | 1.96x |
| Interest coverage | 11.7x |
| Share count CAGR (buyback) | -0.5% |
| Burning cash | no |
Bullet Takeaways
- Parker-Hannifin makes the motion and control components, hydraulics, pneumatics, filtration, and aerospace systems, that go inside other companies' machines and aircraft, split about 69% diversified industrial and 31% aerospace.
- Aerospace is the growth engine, with the segment's organic sales expected to rise around 12% in fiscal 2026 and a high-margin aftermarket that keeps earning as installed equipment is serviced for decades.
- The defining tension is the price, which trades above every valuation method's estimate and at roughly 35 times trailing earnings, leaving little room if the industrial side cools or the aerospace cycle turns.
Bull Case
Parker-Hannifin is best understood by its stage: a mature industrial that has quietly transformed into a higher-margin, aerospace-tilted compounder, and the market is treating it like the latter. The company spent years acquiring its way deeper into aerospace and motion-control systems and applying its internal operating playbook to lift margins across the portfolio. The result is a business that no longer trades like a cyclical parts maker. Full-year fiscal 2026 adjusted segment operating margin is guided to about 27.2%, up roughly 110 basis points, with incremental margins on new revenue forecast around 40%. A 40% incremental margin means each additional dollar of sales drops a large share straight to operating profit, which is how an industrial generates operating leverage as volumes grow.
The aerospace business is the crown jewel, and it has the most attractive economics in the company. Parker's components go onto aircraft at the original-equipment stage, then earn high-margin aftermarket revenue for the decades those aircraft fly, because every part eventually needs service and replacement and Parker is the qualified supplier. In a recent quarter the aerospace mix ran roughly half OEM and half aftermarket, with both growing strongly, OEM organic growth in the low 20s and aftermarket in the mid-teens. Aftermarket revenue is the recurring annuity inside a cyclical industry: it depends on flight hours and fleet age, not on new aircraft orders, so it cushions the cycle. Parker expects aerospace organic sales up about 12% for fiscal 2026.
The financial profile backs the premium. Parker earns a return on equity near 24%, generates about $3.7 billion in free cash flow, and carries a healthy balance sheet, net debt under two times operating income with interest coverage near 12 times. Q2 fiscal 2026 set a record at about $5.17 billion in sales, up 9% with organic growth of 6.6%, and management raised full-year guidance to adjusted EPS of about $30.40 to $31.00. The bull case is a well-run industrial that has re-rated itself toward aerospace economics, with operating leverage, an aftermarket annuity, and a balance sheet strong enough to keep acquiring and returning capital.
Bear Case
The variable with the most leverage over this thesis is the economic cycle, and the price gives that risk almost no respect. Parker's diversified industrial segment, about 69% of the business, sells into manufacturing, construction, agriculture, energy, and transportation, all of which rise and fall with industrial activity and capital spending. When factory output slows, machine builders cut orders for the hydraulics and filtration Parker supplies, and the revenue that drops carries that same 40% incremental margin in reverse: a dollar of lost sales takes a large share of profit with it. The current results reflect a favorable industrial backdrop and a booming aerospace cycle. Neither lasts forever, and a downturn in industrial demand, driven by rates, capital-spending pullbacks, or a manufacturing recession, would compress the margins the price extrapolates.
The valuation is where the bear case is most concrete, because it is genuinely stretched. No family of valuation method reaches the price. The stock trades at roughly 35 times trailing earnings, far above its industrial peer set, and capitalizing its current earnings power or free cash flow with no growth lands at a fraction of the price. Even the asset and book-value methods, anchored on a book value of about $114 per share, sit well below. The price embeds an operating margin holding above 20% and durable growth, an assumption that ranks among the more demanding in the industrial sector. When every standard lens says expensive, the entire price is a bet on the aerospace strength and the margin expansion continuing uninterrupted, and there is no valuation cushion if either pauses.
The aerospace cycle, the bull's strongest argument, is itself a cyclical force the bear has to weigh. Aftermarket revenue is sticky, but OEM aerospace demand depends on aircraft build rates, which are tied to airline profitability and order cycles that have historically swung hard. The current aerospace boom, with OEM organic growth in the low 20s, is a cyclical high, not a steady state. A pause in aircraft production rates, a defense-budget shift, or an airline demand shock would slow the segment that is carrying the growth story and justifying the premium. The bear case is not that Parker is a weak company, it is an excellent one, but that paying 35 times earnings for a business with a 69% cyclical core, at the top of both an industrial and an aerospace cycle, leaves the price exposed to the reversion that cycles always eventually bring.
Valuation
Parker-Hannifin is a multi-segment industrial, and the right comparison is to its capital-goods peers rather than to the market, weighting the high-multiple aerospace business against the more cyclical industrial core. The price is making a demanding bet: that Parker sustains an operating margin above 20% and durable growth, with the inversion showing the price requiring the company to hold close to its current 22.8% margin rather than fade. For a business two-thirds exposed to the industrial cycle, an assumption that peak-cycle margins persist is the heart of what makes the price stretched.
The methods do not disagree here; they uniformly say expensive. No family reaches the price. The forward-growth methods get closest, with the discounted exit-multiple approach landing near the price by holding today's enterprise multiple flat across the forecast. The peer-multiple lens, at roughly a 23 times blended earnings multiple, sits below the price, and the static earnings-power and asset methods land far below it, because capitalizing current earnings with no growth, or anchoring on book value, cannot reach a price trading around 35 times trailing earnings. That pattern, the price above every family's central estimate, marks Parker as a stock priced for its aerospace re-rating and continued margin expansion, a bet beyond what the standard frames support on current numbers. The premium is the market crediting the aerospace mix shift and the operating discipline; the question is whether both hold through a cycle.
Solvency is a genuine strength and bounds the downside, though not the valuation risk. Net debt under two times operating income, interest coverage near 12 times, and about $3.7 billion of free cash flow mean the balance sheet is sound and the dividend and buyback are well covered, with the share count drifting down slightly. For an industrial, that financial strength is what lets Parker keep acquiring and investing through downturns. What the buyer is underwriting is not balance-sheet risk but valuation and cycle risk: paying a premium multiple for a business at the top of both its industrial and aerospace cycles, where the downside is bounded by the quality of the franchise but the return is bounded by how long the peak margins and aerospace growth persist.
Catalysts
Parker-Hannifin's fiscal 2026 has been a story of aerospace strength and raised guidance. Q2 fiscal 2026 delivered record sales of about $5.17 billion, up 9% with organic growth of 6.6%, and the company raised full-year guidance to sales growth of 5.5% to 7.5% and adjusted EPS of about $30.40 to $31.00. The aerospace segment is the driver, with management expecting organic sales up about 12% for the year and, in a recent quarter, OEM organic growth in the low 20s and aftermarket in the mid-teens. Full-year adjusted segment operating margin is guided to about 27.2%, up roughly 110 basis points, on incremental margins near 40%. The next quarterly prints are the read on whether aerospace growth holds and whether the industrial segment's organic growth firms or softens.
The catalysts that move the thesis are the two cycles Parker rides. On aerospace, watch aircraft build rates and aftermarket flight-hour trends, since the segment carrying the growth story depends on both OEM production and fleet servicing demand. On the industrial side, the trajectory of manufacturing activity and capital spending is the swing factor, because the 69% industrial core levers up and down with the broader economy at high incremental margins. Analyst sentiment is constructive, with a Moderate Buy consensus and an average price target around $1,018 against a price near $953. The developments to monitor are the durability of aerospace organic growth, the firmness of industrial demand as the rate environment evolves, and the pace of margin expansion toward the guided 27.2%, since the premium valuation rests on all three continuing.
Peer Cohorts (Per Segment, With Filing Citations)
Diversified Industrial (reported)
- EMR (EMERSON ELECTRIC CO.)
- (no filing in the citation store)
- DOV (DOVER Corp)
- (no filing in the citation store)
- ITW (ILLINOIS TOOL WORKS INC)
- (no filing in the citation store)
- ETN (EATON CORPORATION plc)
- (no filing in the citation store)
- IEX (IDEX CORP)
- (no filing in the citation store)
- PNR (Pentair plc)
- (no filing in the citation store)
- IR (Ingersoll Rand Inc.)
- (no filing in the citation store)
- GGG (GRACO INC.)
- (no filing in the citation store)
- NDSN (NORDSON CORPORATION)
- (no filing in the citation store)
Aerospace Systems (reported)
- HWM (HOWMET AEROSPACE INC.)
- (no filing in the citation store)
- TDG (TransDigm Group Incorporated)
- (no filing in the citation store)
- HEI (HEICO CORPORATION)
- (no filing in the citation store)
- CW (CURTISS-WRIGHT CORPORATION)
- (no filing in the citation store)
- MOG-A (MOOG Inc.)
- (no filing in the citation store)
- WWD (WOODWARD, INC.)
- (no filing in the citation store)
- RTX (RTX CORPORATION)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Parker-Hannifin FY2026 guidance, 2026 · Parker-Hannifin Q3 FY2026 results, 2026 · Parker-Hannifin FY2026 results, 2026 · Parker-Hannifin FY2026 results and guidance, 2026 · analyst consensus, 2026